Tüdőrák: nyitott vizsgálatok itt: Szaúd-Arábia

5 nyitott vizsgálatnak van helyszíne itt: Szaúd-Arábia. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Kísérleti kezelés · 3. fázis · Bristol-Myers Squibb
King Fahad Specialist Hospital - Dammam, Dammam · King Faisal Specialist Hospital, Jeddah · Riyadh
Regiszter frissítve: 2026-11-09
NCT06667076
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Kísérleti kezelés · 2. fázis · Janssen Research & Development, LLC
King Faisal Specialist Hospital & Research Center, Riyadh · King Abdulaziz Medical City, Riyadh · King Saud University Medical City, Riyadh
Regiszter frissítve: 2026-11-03
NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Kísérleti kezelés · 3. fázis · Mirati Therapeutics Inc.
King Faisal Specialist Hospital, Jeddah · King Abdulaziz Medical City - National Guard Hospital, Riyadh · King Faisal Specialist Hospital and Research Center, Riyadh
Regiszter frissítve: 2026-10-27
NCT06758401
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Kísérleti kezelés · 3. fázis · Pfizer
King Faisal Specialist Hospital and Research Center, Riyadh · King Saud University Medical City, Riyadh
Regiszter frissítve: 2026-09-25
NCT05235165
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Kísérleti kezelés · 3. fázis · Children's Oncology Group
King Faisal Specialist Hospital and Research Centre, Riyadh
Regiszter frissítve: 2026-08-25

Minden vizsgálat (Tüdőrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek

Tüdőrák: nyitott vizsgálatok itt: Szaúd-Arábia

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma